Phase 3 Study Evaluating Efficacy and Safety of DSC127 Compared With Vehicle and With Standard-of-care in Diabetic Foot Ulcers
- Conditions
- Diabetic Foot Ulcers
- Interventions
- First Posted Date
- 2013-05-09
- Last Posted Date
- 2017-12-12
- Lead Sponsor
- Integra LifeSciences Corporation
- Target Recruit Count
- 396
- Registration Number
- NCT01849965
- Locations
- đēđ¸
East Valley Foot and Ankle Specialist, Mesa, Arizona, United States
đēđ¸Arizona Burn Center Maricopa Medical Center, Phoenix, Arizona, United States
đēđ¸Associated Foot & Ankle Specialists, PC, Phoenix, Arizona, United States
Open-Label Study in Diabetic Foot Ulcers (DFU), to Evaluate Safety of 0.03% DSC127 Topical Gel in Chronic Use
- Conditions
- Diabetic Foot Ulcer
- Interventions
- Drug: 0.03% DSC127 topical gel
- First Posted Date
- 2013-04-25
- Last Posted Date
- 2017-12-12
- Lead Sponsor
- Integra LifeSciences Corporation
- Target Recruit Count
- 261
- Registration Number
- NCT01840085
- Locations
- đēđ¸
WILMAX Clinical Research, Mobile, Alabama, United States
đēđ¸Reliance Institute of Clinical Research, Chino, California, United States
đēđ¸Roy O. Kroeker, DMP, Inc., Fresno, California, United States
Phase III Study to Evaluate Efficacy and Safety of DSC127 in Diabetic Foot Ulcers
- First Posted Date
- 2013-04-12
- Last Posted Date
- 2017-12-12
- Lead Sponsor
- Integra LifeSciences Corporation
- Target Recruit Count
- 266
- Registration Number
- NCT01830348
- Locations
- đēđ¸
WILMAX Clinical Research Inc, Mobile, Alabama, United States
đēđ¸Center for Clinical Research, Portland, Oregon, United States
đēđ¸Roy O Kroeker, DPM, Inc, Fresno, California, United States
Prospective, Multicenter Observational Study Evaluating the Long Term Safety of the Custombone Implant
- Conditions
- Surgery
- First Posted Date
- 2013-04-05
- Last Posted Date
- 2018-07-02
- Lead Sponsor
- Integra LifeSciences Corporation
- Target Recruit Count
- 110
- Registration Number
- NCT01824706
- Locations
- đĢđˇ
CH Amiens, Amiens, France
đĢđˇCHU Angers, Angers, France
đĢđˇCH de la cote basque, Bayonne, France
Health Economic Assessment of Lower Extremity Diabetic (HEALED) Ulcers With PriMatrix
- Conditions
- Foot Ulcer, Diabetic
- First Posted Date
- 2012-11-20
- Last Posted Date
- 2016-10-18
- Lead Sponsor
- Integra LifeSciences Corporation
- Target Recruit Count
- 92
- Registration Number
- NCT01729286
- Locations
- đēđ¸
University of Southern California, Los Angeles, California, United States
đēđ¸Foot and Ankle Clinic, Los Angeles, California, United States
đēđ¸Advanced Research Institute of Miami, Miami, Florida, United States
Comparison of Balloon Sinuplasty In-Office Versus Medical Management for Recurrent Acute Sinusitis Patients (CABERNET)
- Conditions
- Recurrent Acute Rhinosinusitis
- First Posted Date
- 2012-10-26
- Last Posted Date
- 2024-07-12
- Lead Sponsor
- Integra LifeSciences Corporation
- Target Recruit Count
- 59
- Registration Number
- NCT01714687
Medical Therapy Versus Balloon Sinus Dilation for Patients With Chronic Rhinosinusitis
- Conditions
- Sinusitis
- Interventions
- Device: Balloon sinus dilationDrug: Medical Management
- First Posted Date
- 2012-09-14
- Last Posted Date
- 2024-07-12
- Lead Sponsor
- Integra LifeSciences Corporation
- Target Recruit Count
- 198
- Registration Number
- NCT01685229
A Multi-center, Prospective, Randomized Study With PriMatrix and PriMatrix Ag for the Treatment of Venous Leg Ulcers
- Conditions
- Venous Stasis Ulcer
- First Posted Date
- 2012-06-06
- Last Posted Date
- 2024-04-01
- Lead Sponsor
- Integra LifeSciences Corporation
- Target Recruit Count
- 31
- Registration Number
- NCT01612806
- Locations
- đĩđˇ
Dr. Pila Metropolitan Hospital Wound Healing Center, Ponce, Puerto Rico
đĩđˇCaribbean Clinical Trials, San Juan, Puerto Rico
đĩđˇDoctors' Center Hospital of San Juan, San Juan, Puerto Rico
Earset Healthy Volunteer Study
- Conditions
- Otitis Media
- First Posted Date
- 2012-06-04
- Last Posted Date
- 2024-07-11
- Lead Sponsor
- Integra LifeSciences Corporation
- Target Recruit Count
- 22
- Registration Number
- NCT01611246
- Locations
- đēđ¸
CEI Medical Group, East Palo Alto, California, United States
Tympanostomy Tube Placement in Children in the Office (Inova Study)
- Conditions
- Otitis Media
- First Posted Date
- 2011-12-21
- Last Posted Date
- 2024-08-06
- Lead Sponsor
- Integra LifeSciences Corporation
- Target Recruit Count
- 70
- Registration Number
- NCT01496287
- Locations
- đēđ¸
South Coast Ear, Nose & Throat, Port Saint Lucie, Florida, United States